1	Characterization	characterization	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	mutant	mutant	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	line	line	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	does	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	activate	activate	_	_	_	_	_	_	_
11	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	response	response	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	multiple	multiple	_	_	_	_	_	_	_
16	stimuli	stimulus	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Numerous	numerous	_	_	_	_	_	_	_
2	genes	gene	_	_	_	_	_	_	_
3	required	require	_	_	_	_	_	_	_
4	during	during	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	immune	immune	_	_	_	_	_	_	_
7	or	or	_	_	_	_	_	_	_
8	inflammation	inflammation	_	_	_	_	_	_	_
9	response	response	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	well	well	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	adhesion	adhesion	_	_	_	_	_	_	_
15	process	process	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	regulated	regulate	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	kappaB	kappaB	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Associated	associate	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	its	its	_	_	_	_	_	_	_
4	inhibitor	inhibitor	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	I	i	_	_	_	_	_	_	_
7	kappaB	kappaB	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	resides	reside	_	_	_	_	_	_	_
11	as	as	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	inactive	inactive	_	_	_	_	_	_	_
14	form	form	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cytoplasm	cytoplasm	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Upon	upon	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	various	various	_	_	_	_	_	_	_
5	agents	agent	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	I	i	_	_	_	_	_	_	_
8	kappaB	kappaB	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	proteolyzed	proteolyze	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	translocates	translocate	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	nucleus	nucleus	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	where	where	_	_	_	_	_	_	_
19	it	it	_	_	_	_	_	_	_
20	activates	activate	_	_	_	_	_	_	_
21	its	its	_	_	_	_	_	_	_
22	target	target	_	_	_	_	_	_	_
23	genes	gene	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transduction	transduction	_	_	_	_	_	_	_
3	pathways	pathway	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	lead	lead	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	I	i	_	_	_	_	_	_	_
8	kappaB	kappab	_	_	_	_	_	_	_
9	inactivation	inactivation	_	_	_	_	_	_	_
10	remain	remain	_	_	_	_	_	_	_
11	poorly	poorly	_	_	_	_	_	_	_
12	understood	understand	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	have	have	_	_	_	_	_	_	_
7	characterized	characterize	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	cellular	cellular	_	_	_	_	_	_	_
10	mutant	mutant	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	70/Z3-derived	70/z3-derived	_	_	_	_	_	_	_
14	1.3E2	1.3e2	_	_	_	_	_	_	_
15	murine	murine	_	_	_	_	_	_	_
16	pre-B	pre-b	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	line	line	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	does	do	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	activate	activate	_	_	_	_	_	_	_
24	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	response	response	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	several	several	_	_	_	_	_	_	_
29	stimuli	stimulus	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	demonstrate	demonstrate	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	upon	upon	_	_	_	_	_	_	_
5	stimulation	stimulation	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	Taxol	Taxol	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	phorbol	phorbol	_	_	_	_	_	_	_
12	myristate	myristate	_	_	_	_	_	_	_
13	acetate	acetate	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	interleukin-1	interleukin-1	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	double-stranded	double-stranded	_	_	_	_	_	_	_
19	RNA	RNA	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	I	i	_	_	_	_	_	_	_
22	kappaB	kappab	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	degraded	degrade	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	as	as	_	_	_	_	_	_	_
29	a	a	_	_	_	_	_	_	_
30	result	result	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	an	an	_	_	_	_	_	_	_
33	absence	absence	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	induced	induce	_	_	_	_	_	_	_
36	phosphorylation	phosphorylation	_	_	_	_	_	_	_
37	on	on	_	_	_	_	_	_	_
38	serines	serine	_	_	_	_	_	_	_
39	32	32	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	36	36	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	Neither	neither	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	mutation	mutation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	I	i	_	_	_	_	_	_	_
6	kappaB	kappab	_	_	_	_	_	_	_
7	alpha	alpha	_	_	_	_	_	_	_
8	nor	nor	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	mutation	mutation	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	p50	p50	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	relA	relA	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	two	two	_	_	_	_	_	_	_
18	major	major	_	_	_	_	_	_	_
19	subunits	subunit	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	this	this	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	line	line	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	accounts	account	_	_	_	_	_	_	_
28	for	for	_	_	_	_	_	_	_
29	this	this	_	_	_	_	_	_	_
30	phosphorylation	phosphorylation	_	_	_	_	_	_	_
31	defect	defect	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	well	well	_	_	_	_	_	_	_
3	as	as	_	_	_	_	_	_	_
4	culminating	culminate	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	inducible	inducible	_	_	_	_	_	_	_
8	phosphorylation	phosphorylation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	I	i	_	_	_	_	_	_	_
11	kappaB	kappab	_	_	_	_	_	_	_
12	alpha	alpha	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	serines	serine	_	_	_	_	_	_	_
15	32	32	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	36	36	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	all	all	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	stimuli	stimulus	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	are	be	_	_	_	_	_	_	_
24	inactive	inactive	_	_	_	_	_	_	_
25	on	on	_	_	_	_	_	_	_
26	1.3E2	1.3e2	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	exhibit	exhibit	_	_	_	_	_	_	_
29	a	a	_	_	_	_	_	_	_
30	sensitivity	sensitivity	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	antioxidant	antioxidant	_	_	_	_	_	_	_
34	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
35	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	PDTC	PDTC	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	stimuli	stimulus	_	_	_	_	_	_	_
5	such	such	_	_	_	_	_	_	_
6	as	as	_	_	_	_	_	_	_
7	hyperosmotic	hyperosmotic	_	_	_	_	_	_	_
8	shock	shock	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	phosphatase	phosphatase	_	_	_	_	_	_	_
11	inhibitors	inhibitor	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	use	use	_	_	_	_	_	_	_
15	PDTC-insensitive	pdtc-insensitive	_	_	_	_	_	_	_
16	pathways	pathway	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	induce	induce	_	_	_	_	_	_	_
19	I	i	_	_	_	_	_	_	_
20	kappaB	kappab	_	_	_	_	_	_	_
21	alpha	alpha	_	_	_	_	_	_	_
22	degradation	degradation	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	1.3E2	1.3e2	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	redox	redox	_	_	_	_	_	_	_
5	status	status	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	1.3E2	1.3e2	_	_	_	_	_	_	_
8	does	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	reveal	reveal	_	_	_	_	_	_	_
11	any	any	_	_	_	_	_	_	_
12	difference	difference	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	wild-type	wild-type	_	_	_	_	_	_	_
15	70Z/3	70z/3	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	T-cell	t-cell	_	_	_	_	_	_	_
8	leukemia	leukemia	_	_	_	_	_	_	_
9	virus	virus	_	_	_	_	_	_	_
10	type	type	_	_	_	_	_	_	_
11	1	1	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	HTLV-1)-derived	htlv-1)-derived	_	_	_	_	_	_	_
14	Tax	Tax	_	_	_	_	_	_	_
15	trans-activator	trans-activator	_	_	_	_	_	_	_
16	induces	induce	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	1.3E2	1.3e2	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	suggesting	suggest	_	_	_	_	_	_	_
23	that	that	_	_	_	_	_	_	_
24	this	this	_	_	_	_	_	_	_
25	viral	viral	_	_	_	_	_	_	_
26	protein	protein	_	_	_	_	_	_	_
27	does	do	_	_	_	_	_	_	_
28	not	not	_	_	_	_	_	_	_
29	operate	operate	_	_	_	_	_	_	_
30	via	via	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	defective	defective	_	_	_	_	_	_	_
33	pathway	pathway	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	show	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	two	two	_	_	_	_	_	_	_
7	other	other	_	_	_	_	_	_	_
8	I	i	_	_	_	_	_	_	_
9	kappaB	kappab	_	_	_	_	_	_	_
10	molecules	molecule	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	I	i	_	_	_	_	_	_	_
13	kappaB	kappab	_	_	_	_	_	_	_
14	beta	beta	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	recently	recently	_	_	_	_	_	_	_
18	identified	identify	_	_	_	_	_	_	_
19	I	i	_	_	_	_	_	_	_
20	kappaB	kappab	_	_	_	_	_	_	_
21	epsilon	epsilon	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	are	be	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	degraded	degrade	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	1.3E2	1.3e2	_	_	_	_	_	_	_
29	cell	cell	_	_	_	_	_	_	_
30	line	line	_	_	_	_	_	_	_
31	following	follow	_	_	_	_	_	_	_
32	stimulation	stimulation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	1.3E2	1.3e2	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	cellular	cellular	_	_	_	_	_	_	_
9	transduction	transduction	_	_	_	_	_	_	_
10	mutant	mutant	_	_	_	_	_	_	_
11	exhibiting	exhibit	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	defect	defect	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	step	step	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	required	require	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	several	several	_	_	_	_	_	_	_
22	different	different	_	_	_	_	_	_	_
23	stimuli	stimulus	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	activate	activate	_	_	_	_	_	_	_
26	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	analysis	analysis	_	_	_	_	_	_	_
6	suggests	suggest	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	common	common	_	_	_	_	_	_	_
9	step	step	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	signaling	signaling	_	_	_	_	_	_	_
13	pathways	pathway	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	trigger	trigger	_	_	_	_	_	_	_
16	I	i	_	_	_	_	_	_	_
17	kappaB	kappab	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	I	i	_	_	_	_	_	_	_
21	kappaB	kappab	_	_	_	_	_	_	_
22	beta	beta	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	I	i	_	_	_	_	_	_	_
26	kappaB	kappab	_	_	_	_	_	_	_
27	epsilon	epsilon	_	_	_	_	_	_	_
28	degradation	degradation	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

